nach oben

Erschienen in:

20.06.2018 | Original Article

Melatonin treatment suppresses appetite genes and improves adipose tissue plasticity in diet-induced obese zebrafish

verfasst von: G. Montalbano, M. Mania, F. Abbate, M. Navarra, M. C. Guerrera, R. Laura, J. A. Vega, M. Levanti, A. Germanà

Erschienen in: Endocrine | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Overweight and obesity are important risk factors for diabetes, cardiovascular diseases, and premature death in modern society. Recently, numerous natural and synthetic compounds have been tested in diet-induced obese animal models, to counteract obesity. Melatonin is a circadian hormone, produced by pineal gland and extra-pineal sources, involved in processes which have in common a rhythmic expression. In teleost, it can control energy balance by activating or inhibiting appetite-related peptides. The study aims at testing effects of melatonin administration to control-fed and overfed zebrafish, in terms of expression levels of orexigenic (Ghrelin, orexin, NPY) and anorexigenic (leptin, POMC) genes expression and morphometry of visceral and subcutaneous fat depots.

Methods

Adult male zebrafish (n = 56) were divided into four dietary groups: control, overfed, control + melatonin, overfed + melatonin. The treatment lasted 5 weeks and BMI levels of every fish were measured each week. After this period fishes were sacrificed; morphological and morphometric studies have been carried out on histological sections of adipose tissue and adipocytes. Moreover, whole zebrafish brain and intestine were used for qRT-PCR.

Results

Our results demonstrate that melatonin supplementation may have an effect in mobilizing fat stores, in increasing basal metabolism and thus in preventing further excess fat accumulation. Melatonin stimulates the anorexigenic and inhibit the orexigenic signals.

Conclusions

It seems that adequate melatonin treatment exerts anti-obesity protective effects, also in a diet-induced obesity zebrafish model, that might be the result of the restoration of many factors: the final endpoint reached is weight loss and stabilization of weight gain.

D.W. Haslam, W.P. James, Obesity. Lancet 366(9492), 1197–1209 (2005). https://doi.org/10.1016/S0140-6736(05)67483-1 CrossRefPubMed

M. Cecchini, F. Sassi, Tackling obesity requires efficient government policies. Isr. J. Health Policy Res. 1(1), 18 (2012). https://doi.org/10.1186/2045-4015-1-18 CrossRefPubMedPubMedCentral

T. Magrone, E. Jirillo, Childhood obesity: immune response and nutritional approaches. Front. Immunol. 6, 76 (2015). https://doi.org/10.3389/fimmu.2015.00076 CrossRefPubMedPubMedCentral

N.M. Iyengar, C.A. Hudis, A.J. Dannenberg, Obesity and inflammation: new insights into breast cancer development and progression. Am. Soc. Clin. Oncol. Educ. Book (2013). https://doi.org/10.1200/EdBook_AM.2013.33.46CrossRef

J.R. Speakman, Functional analysis of seven genes linked to body mass index and adiposity by genome-wide association studies: a review. Hum. Hered. 75(2-4), 57–79 (2013). https://doi.org/10.1159/000353585 CrossRefPubMed

B. de Luxán-Delgado, B. Caballero, Y. Potes, A. Rubio-González, I. Rodríguez, J. Gutiérrez-Rodríguez, J.J. Solano, A. Coto-Montes, Melatonin administration decreases adipogenesis in the liver of ob/ob mice through autophagy modulation. J. Pineal Res. 56(2), 126–133 (2014). https://doi.org/10.1111/jpi.12104 CrossRefPubMed

R.J. Reiter, D.X. Tan, L. Fuentes-Broto, Melatonin: a multitasking molecule. Prog. Brain. Res. 181, 127–151 (2010). https://doi.org/10.1016/S0079-6123(08)81008-4 CrossRefPubMed

J. Cipolla-Neto, F.G. Amaral, S.C. Afeche, D.X. Tan, R.J. Reiter, Melatonin, energy metabolism, and obesity: a review. J. Pineal Res. 56(4), 371–381 (2014). https://doi.org/10.1111/jpi.12137 CrossRefPubMed

D. Zephy, J. Ahmad, Type 2 diabetes mellitus: role of melatonin and oxidative stress. Diabetes Metab. Syndr. 9(2), 127–131 (2015). https://doi.org/10.1016/j.dsx.2014.09.018 CrossRefPubMed

10.

D. Gnocchi, G. Bruscalup, Circadian rhythms and hormonal homeostasis: pathophysiological implications. Biology 6(1) (2017). https://doi.org/10.3390/biology6010010.CrossRef

11.

S.R. Pandi-Perumal, V. Srinivasan, G.J. Maestroni, D.P. Cardinali, B. Poeggeler, R. Hardeland, Melatonin: Nature’s most versatile biological signal? Febs. J. 273(13), 2813–2838 (2006). https://doi.org/10.1111/j.1742-4658.2006.05322.x CrossRefPubMed

12.

R.J. Reiter, D.X. Tan, A. Korkmaz, S. Ma, Obesity and metabolic syndrome: association with chronodisruption, sleep deprivation, and melatonin suppression. Ann. Med. 44(6), 564–577 (2012). https://doi.org/10.3109/07853890.2011.586365 CrossRefPubMed

13.

M.B. Arnao, J. Hernandez-Ruiz, Functions of melatonin in plants: a review. J. Pineal Res. 59(2), 133–150 (2015). https://doi.org/10.1111/jpi.12253 CrossRefPubMed

14.

G.A. Bubenik, Gastrointestinal melatonin: localization, function, and clinical relevance. Dig. Dis. Sci. 47(10), 2336–2348 (2002)CrossRef

15.

O. Lepage, E.T. Larson, I. Mayer, S. Winberg, Tryptophan affects both gastrointestinal melatonin production and interrenal activity in stressed and nonstressed rainbow trout. J. Pineal Res. 38(4), 264–271 (2005). https://doi.org/10.1111/j.1600-079X.2004.00201.x CrossRefPubMed

16.

C.C. Piccinetti, B. Migliarini, I. Olivotto, M.P. Simoniello, E. Giorgini, O. Carnevali, Melatonin and peripheral circuitries: insights on appetite and metabolism in Danio rerio. Zebrafish 10(3), 275–282 (2013). https://doi.org/10.1089/zeb.2012.0844 CrossRefPubMedPubMedCentral

17.

M.L. Pinillos, N. De Pedro, A.L. Alonso-Gomez, M. Alonso-Bedate, M.J. Delgado, Food intake inhibition by melatonin in goldfish (Carassius auratus). Physiol. Behav. 72(5), 629–634 (2001)CrossRef

18.

J. Falcon, L. Besseau, S. Sauzet, G. Boeuf, Melatonin effects on the hypothalamo-pituitary axis in fish. Trends Endocrinol. Metab. 18(2), 81–88 (2007). https://doi.org/10.1016/j.tem.2007.01.002 CrossRefPubMed

19.

N. De Pedro, R.M. Martinez-Alvarez, M.J. Delgado, Melatonin reduces body weight in goldfish (Carassius auratus): effects on metabolic resources and some feeding regulators. J. Pineal Res. 45(1), 32–39 (2008). https://doi.org/10.1111/j.1600-079X.2007.00553.x CrossRefPubMed

20.

C.C. Piccinetti, B. Migliarini, I. Olivotto, G. Coletti, A. Amici, O. Carnevali, Appetite regulation: the central role of melatonin in Danio rerio. Horm. Behav. 58(5), 780–785 (2010). https://doi.org/10.1016/j.yhbeh.2010.07.013 CrossRefPubMed

21.

D.X. Tan, L.C. Manchester, L. Fuentes-Broto, S.D. Paredes, R.J. Reiter, Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes. Rev. 12(3), 167–188 (2011). https://doi.org/10.1111/j.1467-789X.2010.00756.x CrossRefPubMed

22.

P.J. Lardone, S.N. Alvarez-Sanchez, J.M. Guerrero, A. Carrillo-Vico, Melatonin and glucose metabolism: clinical relevance. Curr. Pharm. Des. 20(30), 4841–4853 (2014)CrossRef

23.

R. Hardeland, D.P. Cardinali, V. Srinivasan, D.W. Spence, G.M. Brown, S.R. Pandi-Perumal, Melatonin--a pleiotropic, orchestrating regulator molecule. Prog. Neurobiol. 93(3), 350–384 (2011). https://doi.org/10.1016/j.pneurobio.2010.12.004 CrossRefPubMed

24.

I. Vinogradova, V. Anisimov, Melatonin prevents the development of the metabolic syndrome in male rats exposed to different light/dark regimens. Biogerontology 14(4), 401–409 (2013). https://doi.org/10.1007/s10522-013-9437-4 CrossRefPubMed

25.

J.P. Chaput, Sleep patterns, diet quality and energy balance. Physiol. Behav. 134, 86–91 (2014). https://doi.org/10.1016/j.physbeh.2013.09.006 CrossRefPubMed

26.

A.W. McHill, A.J. Phillips, C.A. Czeisler, L. Keating, K. Yee, L.K. Barger, M. Garaulet, F.A. Scheer, E.B. Klerman, Later circadian timing of food intake is associated with increased body fat. Am. J. Clin. Nutr. 106(5), 1213–1219 (2017). https://doi.org/10.3945/ajcn.117.161588 CrossRefPubMedPubMedCentral

27.

A. Seth, D.L. Stemple, I. Barroso, The emerging use of zebrafish to model metabolic disease. Dis. Models & Mech. 6(5), 1080–1088 (2013). https://doi.org/10.1242/dmm.011346 CrossRef

28.

T. Oka, Y. Nishimura, L. Zang, M. Hirano, Y. Shimada, Z. Wang, N. Umemoto, J. Kuroyanagi, N. Nishimura, T. Tanaka, Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol. 10, 21 (2010). https://doi.org/10.1186/1472-6793-10-21 CrossRefPubMedPubMedCentral

29.

G. Montalbano, M. Mania, M.C. Guerrera, F. Abbate, R. Laurà, M. Navarra, J.A. Vega, E. Ciriaco, A. Germanà, Morphological differences in adipose tissue and changes in BDNF/Trkb expression in brain and gut of a diet induced obese zebrafish model. Ann. Anat. 204, 36–44 (2015). https://doi.org/10.1016/j.aanat.2015.11.003 CrossRefPubMed

30.

S.K. McMenamin, J.E. Minchin, T.N. Gordon, J.F. Rawls, D.M. Parichy, Dwarfism and increased adiposity in the gh1 mutant zebrafish vizzini. Endocrinology 154(4), 1476–1487 (2013). https://doi.org/10.1210/en.2012-1734 CrossRefPubMedPubMedCentral

31.

J.E.N. Minchin, J.F. Rawls, A classification system for zebrafish adipose tissues. Dis. Model Mech. 10(6), 797–809 (2017). https://doi.org/10.1242/dmm.025759 CrossRefPubMedPubMedCentral

32.

M.B. Levanti, M.C. Guerrera, M.G. Calavia, E. Ciriaco, G. Montalbano, J. Cobo, A. Germana, J.A. Vega, Acid-sensing ion channel 2 (ASIC2) in the intestine of adult zebrafish. Neurosci. Lett. 494(1), 24–28 (2011). https://doi.org/10.1016/j.neulet.2011.02.046 CrossRefPubMed

33.

F. Abbate, M.C. Guerrera, G. Montalbano, M.B. Levanti, G.P. Germanà, M. Navarra, R. Laurà, J.A. Vega, E. Ciriaco, A. Germanà, Expression and anatomical distribution of TrkB in the encephalon of the adult zebrafish (Danio rerio). Neurosci. Lett. 563, 66–69 (2014). https://doi.org/10.1016/j.neulet.2014.01.031 CrossRefPubMed

34.

M.L. Bonet, P. Oliver, A. Palou, Pharmacological and nutritional agents promoting browning of white adipose tissue. Biochim. Biophys. Acta 1831(5), 969–985 (2013). https://doi.org/10.1016/j.bbalip.2012.12.002 CrossRefPubMed

35.

H. Zhu, Q. Jin, Y. Li, Q. Ma, J. Wang, D. Li, H. Zhou, Y. Chen, Melatonin protected cardiac microvascular endothelial cells against oxidative stress injury via suppression of IP3R-[Ca(2+)]c/VDAC-[Ca(2+)]m axis by activation of MAPK/ERK signaling pathway. Cell Stress Chaperon-. 23(1), 101–113 (2018). https://doi.org/10.1007/s12192-017-0827-4 CrossRef

36.

S. Roman, A. Agil, M. Peran, E. Alvaro-Galue, F.J. Ruiz-Ojeda, G. Fernandez-Vazquez, J.A. Marchal, Brown adipose tissue and novel therapeutic approaches to treat metabolic disorders. Transl. Res. 165(4), 464–479 (2015). https://doi.org/10.1016/j.trsl.2014.11.002 CrossRefPubMed

37.

G. Favero, A. Stacchiotti, S. Castrezzati, F. Bonomini, M. Albanese, R. Rezzani, L.F. Rodella, Melatonin reduces obesity and restores adipokine patterns and metabolism in obese (ob/ob) mice. Nutr. Res. 35(10), 891–900 (2015). https://doi.org/10.1016/j.nutres.2015.07.001 CrossRefPubMed

38.

R.J. Reiter, Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12(2), 151–180 (1991). https://doi.org/10.1210/edrv-12-2-151 CrossRefPubMed

39.

H. Gurer-Orhan, S. Suzen, Melatonin, its metabolites and its synthetic analogs as multi-faceted compounds: antioxidant, prooxidant and inhibitor of bioactivation reactions. Curr. Med. Chem. 22(4), 490–499 (2015)CrossRef

40.

M. Gallagher, W.D. Brown, Composition of San Francisco bay brine shrimp (Artemia salina). J. Agric. Food Chem. 23(4), 630–632 (1975). https://doi.org/10.1021/jf60200a008 CrossRefPubMed

41.

R.Y. Xu, Y.P. Wan, Q.Y. Tang, J. Wu, W. Cai, The effects of high fat on central appetite genes in Wistar rats: a microarray analysis. Clin. Chim. Acta 397(1-2), 96–100 (2008). https://doi.org/10.1016/j.cca.2008.07.027 CrossRefPubMed

42.

V. Srinivasan, Y. Ohta, J. Espino, J.A. Pariente, A.B. Rodriguez, M. Mohamed, R. Zakaria, Metabolic syndrome, its pathophysiology and the role of melatonin. Recent Pat. Endocr. Metab. Immun. Drug Discov. 7(1), 11–25 (2013)CrossRef

43.

N. De Pedro, R.M. Martínez-Alvarez, M.J. Delgado, Melatonin reduces body weight in goldfish (Carassius auratus): effects on metabolic resources and some feeding regulators. J. Pineal Res. 45(1), 32–39 (2008). https://doi.org/10.1111/j.1600-079X.2007.00553.x CrossRefPubMed

44.

B. Perry, Y. Wang, Appetite regulation and weight control: the role of gut hormones. Nutr. Diabetes 2, e26 (2012). https://doi.org/10.1038/nutd.2011.21 CrossRefPubMedPubMedCentral

45.

B. Prunet-Marcassus, M. Desbazeille, A. Bros, K. Louche, P. Delagrange, P. Renard, L. Casteilla, L. Penicaud, Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology 144(12), 5347–5352 (2003). https://doi.org/10.1210/en.2003-0693 CrossRefPubMed

46.

F. Nduhirabandi, E.F. du Toit, A. Lochner, Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities? Acta Physiol. 205(2), 209–223 (2012). https://doi.org/10.1111/j.1748-1716.2012.02410.x CrossRef

47.

E. Lima-Cabello, M.E. Diaz-Casado, J.A. Guerrero, B.B. Otalora, G. Escames, L.C. Lopez, R.J. Reiter, D. Acuna-Castroviejo, A review of the melatonin functions in zebrafish physiology. J. Pineal Res. 57(1), 1–9 (2014). https://doi.org/10.1111/jpi.12149 CrossRefPubMed

48.

F. Nduhirabandi, B. Huisamen, H. Strijdom, D. Blackhurst, A. Lochner, Short-term melatonin consumption protects the heart of obese rats independent of body weight change and visceral adiposity. J. Pineal Res. 57(3), 317–332 (2014). https://doi.org/10.1111/jpi.12171 CrossRefPubMed

49.

K. Szewczyk-Golec, P. Rajewski, M. Gackowski, C. Mila-Kierzenkowska, R. Wesołowski, P. Sutkowy, M. Pawłowska, A. Woźniak, Melatonin supplementation lowers oxidative stress and regulates adipokines in obese patients on a calorie-restricted diet. Oxid. Med. Cell Longev. 2017, 8494107 (2017). https://doi.org/10.1155/2017/8494107 CrossRefPubMedPubMedCentral

50.

C.C. Piccinetti, L.A. Ricci, N. Tokle, G. Radaelli, F. Pascoli, L. Cossignani, F. Palermo, G. Mosconi, V. Nozzi, F. Raccanello, I. Olivotto, Malnutrition may affect common sole (Solea solea L.) growth, pigmentation and stress response: molecular, biochemical and histological implications. Comparative biochemistry and physiology. Part A Mol. Integr. Physiol. 161(4), 361–371 (2012). https://doi.org/10.1016/j.cbpa.2011.12.009 CrossRef

51.

F. García-García, E. Juárez-Aguilar, J. Santiago-García, D.P. Cardinali, Ghrelin and its interactions with growth hormone, leptin and orexins: implications for the sleep-wake cycle and metabolism. Sleep. Med. Rev. 18(1), 89–97 (2014). https://doi.org/10.1016/j.smrv.2013.04.003 CrossRefPubMed

52.

H. Mangge, K. Summers, G. Almer, R. Prassl, D. Weghuber, W. Schnedl, D. Fuchs, Antioxidant food supplements and obesity-related inflammation. Curr. Med. Chem. 20(18), 2330–2337 (2013)CrossRef

53.

C.E. Perez-Leighton, C.J. Billington, C.M. Kotz, Orexin modulation of adipose tissue. Biochim. Biophys. Acta 1842(3), 440–445 (2014). https://doi.org/10.1016/j.bbadis.2013.06.007 CrossRefPubMed

54.

C. Kotz, J. Nixon, T. Butterick, C. Perez-Leighton, J. Teske, C. Billington, Brain orexin promotes obesity resistance. Ann. N. Y. Acad. Sci. 1264, 72–86 (2012). https://doi.org/10.1111/j.1749-6632.2012.06585.x CrossRefPubMedPubMedCentral

55.

C.M. Novak, C.M. Kotz, J.A. Levine, Central orexin sensitivity, physical activity, and obesity in diet-induced obese and diet-resistant rats. Am. J. Physiol. Endocrinol. Metab. 290(2), E396–403 (2006). https://doi.org/10.1152/ajpendo.00293.2005 CrossRefPubMed

56.

R.D. Cone, The Central Melanocortin System and Energy Homeostasis. Trends Endocrinol. Metab. 10(6), 211–216 (1999)CrossRef

57.

J.M. Cerda-Reverter, M.J. Agulleiro, R.G. R, E. Sanchez, R. Ceinos, J. Rotllant, Fish melanocortin system. Eur. J. Pharmacol. 660(1), 53–60 (2011). https://doi.org/10.1016/j.ejphar.2010.10.108 CrossRefPubMed

58.

I. Gantz, T.M. Fong, The melanocortin system. Am. J. Physiol. Endocrinol. Metab. 284(3), E468–474 (2003). https://doi.org/10.1152/ajpendo.00434.2002 CrossRefPubMed

59.

E. Valassi, M. Scacchi, F. Cavagnini, Neuroendocrine control of food intake. Nutr., Metab., Cardiovasc. Dis. 18(2), 158–168 (2008). https://doi.org/10.1016/j.numecd.2007.06.004 CrossRef

60.

A. Agil, M. El-Hammadi, A. Jimenez-Aranda, M. Tassi, W. Abdo, G. Fernandez-Vazquez, R.J. Reiter, Melatonin reduces hepatic mitochondrial dysfunction in diabetic obese rats. J. Pineal Res. 59(1), 70–79 (2015). https://doi.org/10.1111/jpi.12241 CrossRefPubMed

Titel: Melatonin treatment suppresses appetite genes and improves adipose tissue plasticity in diet-induced obese zebrafish
verfasst von: G. Montalbano
M. Mania
F. Abbate
M. Navarra
M. C. Guerrera
R. Laura
J. A. Vega
M. Levanti
A. Germanà
Publikationsdatum: 20.06.2018
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 2/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-018-1653-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Melatonin treatment suppresses appetite genes and improves adipose tissue plasticity in diet-induced obese zebrafish

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma

Androgenic modulation of AR-Vs

Efficacy and safety of cooled and uncooled microwave ablation for the treatment of benign thyroid nodules: a systematic review and meta-analysis

Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas

Insulin regulates glucagon-like peptide-1 secretion by pancreatic alpha cells

LncRNAs and miRs as epigenetic signatures in diabetic cardiac fibrosis: new advances and perspectives

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin